4.4 Review

Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma

期刊

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1586/EGH.11.105

关键词

hepatocellular carcinoma; hepatologist; interventional radiologist; medical oncologist; multidisciplinary team; natural history; outcomes; surgical oncologist; targeted therapy; treatment

资金

  1. Bayer Healthcare Pharmaceuticals
  2. Onyx Pharmaceuticals, Inc.
  3. Bristo-Myers Squibb, Inc.

向作者/读者索取更多资源

It has long been appreciated that hepatocellular carcinoma (HCC) is a complex disease. HCC is typically preceded by liver cirrhosis, which is itself caused by various types of hepatitis of both viral and nonviral etiologies. Thus, the treatment of patients with HCC requires multiple healthcare professionals, including hepatologists, medical oncologists, surgical oncologists, transplantation surgeons, diagnostic radiologists, pathologists, nurses, nurse practitioners and interventional radiologists. These specialists should meet regularly to review patients' progress, ensure that treatments are individualized for each patient and agree on next steps. We review case presentations provided by the authors to illustrate the benefits and advantages of the multidisciplinary team matrix in the management of patients with HCC, including the effects of this treatment technique on patient outcome, survival and quality of life.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据